Classification and Severity Assessment of Obesity in Clinical Risk Prediction of Multimorbidity Trajectories

IF 2.4 Q3 ENDOCRINOLOGY & METABOLISM
Clinical Obesity Pub Date : 2026-07-15 DOI:10.1111/cob.70097
Afua Ampadu-Yeboah, Alistair Carr, Frederick Ho, Jason Gill, Naveed Sattar, Bhautesh Dinesh Jani
{"title":"Classification and Severity Assessment of Obesity in Clinical Risk Prediction of Multimorbidity Trajectories","authors":"Afua Ampadu-Yeboah,&nbsp;Alistair Carr,&nbsp;Frederick Ho,&nbsp;Jason Gill,&nbsp;Naveed Sattar,&nbsp;Bhautesh Dinesh Jani","doi":"10.1111/cob.70097","DOIUrl":null,"url":null,"abstract":"<p>Obesity is a key risk factor for chronic disease and multimorbidity, yet variation in how obesity is defined may influence risk estimation in clinical practise. Waist-to-hip ratio (WHR) and waist-to-height ratio (WHtR) are better at capturing fat distribution than body mass index (BMI) and may have a role in obesity related multimorbidity prediction. To examine multimorbidity risk across obesity groups classified using BMI in combination with WHR/WHtR. A UK Biobank cohort free of comorbidity at baseline (<i>n</i> = 179 876) was followed for incident first long-term condition and multimorbidity (≥ 2 of 38 conditions) over a mean of 9.9 years. Six adiposity categories combining BMI with WHR/WHtR were analysed using Cox proportional hazards models. Subgroup analyses evaluated whether high central obesity (WHtR ≥ 0.6) provided additional risk stratification within BMI groups. Combined general with central obesity showed highest risk for the first condition (HR 1.11; 95% CI 1.087–1.138) and multimorbidity (HR 1.13; 95% CI 1.093–1.172). However, BMI-stratified subgroup analyses, central obesity provided additional risk discrimination only among individuals in the overweight category (BMI 25–29.9 kg/m<sup>2</sup>), but not among those with BMI ≥ 30 kg/m<sup>2</sup>. Waist-based measures improved risk identification in adults with overweight BMI, supporting the potential role of combined BMI-waist approaches for earlier multimorbidity prevention.</p>","PeriodicalId":10399,"journal":{"name":"Clinical Obesity","volume":"16 4","pages":""},"PeriodicalIF":2.4000,"publicationDate":"2026-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/cob.70097","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Obesity","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/cob.70097","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Obesity is a key risk factor for chronic disease and multimorbidity, yet variation in how obesity is defined may influence risk estimation in clinical practise. Waist-to-hip ratio (WHR) and waist-to-height ratio (WHtR) are better at capturing fat distribution than body mass index (BMI) and may have a role in obesity related multimorbidity prediction. To examine multimorbidity risk across obesity groups classified using BMI in combination with WHR/WHtR. A UK Biobank cohort free of comorbidity at baseline (n = 179 876) was followed for incident first long-term condition and multimorbidity (≥ 2 of 38 conditions) over a mean of 9.9 years. Six adiposity categories combining BMI with WHR/WHtR were analysed using Cox proportional hazards models. Subgroup analyses evaluated whether high central obesity (WHtR ≥ 0.6) provided additional risk stratification within BMI groups. Combined general with central obesity showed highest risk for the first condition (HR 1.11; 95% CI 1.087–1.138) and multimorbidity (HR 1.13; 95% CI 1.093–1.172). However, BMI-stratified subgroup analyses, central obesity provided additional risk discrimination only among individuals in the overweight category (BMI 25–29.9 kg/m2), but not among those with BMI ≥ 30 kg/m2. Waist-based measures improved risk identification in adults with overweight BMI, supporting the potential role of combined BMI-waist approaches for earlier multimorbidity prevention.

Abstract Image

肥胖症的分类和严重程度评估在多病轨迹的临床风险预测中的作用。
肥胖是慢性疾病和多种疾病的关键危险因素,然而肥胖定义的差异可能会影响临床实践中的风险估计。腰臀比(WHR)和腰高比(WHtR)比身体质量指数(BMI)更能捕捉脂肪分布,可能在肥胖相关的多种疾病预测中发挥作用。通过BMI和腰宽比/腰宽比对肥胖人群进行分类,研究肥胖人群的多病风险。在基线时无合并症的英国生物银行队列(n = 179 876)中,随访了平均9.9年的首次长期发病和多重发病(38种情况中≥2种)。结合BMI和腰臀比/腰臀比的6种肥胖类型采用Cox比例风险模型进行分析。亚组分析评估高中心性肥胖(WHtR≥0.6)是否在BMI组中提供了额外的风险分层。合并全身性肥胖和中心性肥胖的患者首次发病的风险最高(HR 1.11; 95% CI 1.087-1.138),多发病的风险最高(HR 1.13; 95% CI 1.093-1.172)。然而,在BMI分层亚组分析中,中心性肥胖仅在超重类别(BMI 25-29.9 kg/m2)的个体中提供了额外的风险区分,而在BMI≥30 kg/m2的个体中则没有。基于腰围的测量改善了BMI超重成人的风险识别,支持了BMI-腰围联合方法在早期多病预防中的潜在作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinical Obesity
Clinical Obesity ENDOCRINOLOGY & METABOLISM-
CiteScore
5.90
自引率
3.00%
发文量
59
期刊介绍: Clinical Obesity is an international peer-reviewed journal publishing high quality translational and clinical research papers and reviews focussing on obesity and its co-morbidities. Key areas of interest are: • Patient assessment, classification, diagnosis and prognosis • Drug treatments, clinical trials and supporting research • Bariatric surgery and follow-up issues • Surgical approaches to remove body fat • Pharmacological, dietary and behavioural approaches for weight loss • Clinical physiology • Clinically relevant epidemiology • Psychological aspects of obesity • Co-morbidities • Nursing and care of patients with obesity.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书